Enfermedad de Graves
El cannabis está siendo explorado como una terapia complementaria para el manejo de los síntomas asociados con la enfermedad de Graves, un trastorno autoinmune que afecta la glándula tiroides y conduce al hipertiroidismo. Los cannabinoides, como el cannabidiol (CBD), presentan propiedades antiinflamatorias e inmunomoduladoras, las cuales pueden ayudar a reducir la respuesta autoinmune que impulsa la enfermedad de Graves (Kaplan et al., 2003). La capacidad del CBD para suprimir la producción de citocinas proinflamatorias podría aliviar síntomas como la hinchazón y el malestar causados por la inflamación de la tiroides o de los tejidos circundantes (Carrier et al., 2006).
Además, el cannabis ha mostrado potencial para reducir la ansiedad, los temblores y el insomnio, que son síntomas comunes experimentados por las personas con enfermedad de Graves (Blessing et al., 2015).
Aunque el cannabis no puede abordar directamente el desequilibrio de las hormonas tiroideas característico de la enfermedad de Graves, puede ofrecer alivio sintomático, mejorando la calidad de vida de los pacientes. No obstante, se necesita más investigación para determinar los efectos a largo plazo del uso de cannabis en este contexto, especialmente en lo que respecta a su interacción con tratamientos estándar como los medicamentos antitiroideos y la terapia con yodo radiactivo.
References
- 1. Blessing, E. M., Steenkamp, M. M., Manzanares, J., & Marmar, C. R. (2015). Cannabidiol as a potential treatment for anxiety and related disorders. Neurotherapeutics, 12(4), 825-836.
- 2. Carrier, E. J., Auchampach, J. A., & Hillard, C. J. (2006). Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression. Proceedings of the National Academy of Sciences, 103(20), 7895-7900.
- 3. Kaplan, B. L., Springs, A. E., & Kaminski, N. E. (2003). The profile of immune modulation by cannabidiol (CBD) involves deregulation of nuclear factor of activated T cells (NFAT). Journal of Neuroimmune Pharmacology, 25(4), 431-441.
- 4. McPartland, J. M., & Guy, G. W. (2017). The evolution of cannabis and coevolution with the cannabinoid receptor—a hypothesis. Planta Medica, 83(12/13), 201-211.
- 5. Klein, T. W. (2005). Cannabinoid-based drugs as anti-inflammatory therapeutics. Nature Reviews Immunology, 5(5), 400-411.
Servicios relacionados
Cannabis has garnered attention as a potential adjunct therapy for bipolar disorder, offering therapeutic benefits when used…
Cannabis has emerged as a complementary option in managing cancer-related symptoms, providing…
Cannabis has shown promise as a therapeutic option for managing Crohn’s disease, a chronic…
Cannabis has gained recognition as a potential therapy for managing chronic pain, offering relief…
Cannabis is being explored as a potential adjunct therapy for managing depression, offering…
Cannabis, particularly cannabidiol (CBD) has shown significant promise in managing epilepsy,…
Cannabis has been explored as a potential treatment for glaucoma, a condition characterized…
Cannabis is being studied as a potential therapy for managing pain associated with gout, a form of…
Cannabis has demonstrated potential in improving the quality of life for individuals living with..
Cannabis has been studied for its potential to help manage hypertension (high blood pressure), a…
Cannabis has gained as a potential treatment for Irritable Bowel Syndrome (IBS), a gastrointestinal disorder…
Cannabis has gained attention as a potential treatment for insomnia, a common sleep disorder..
Cannabis has shown potential in the treatment of migraines, a neurological condition characterized…
Cannabis has shown potential as a therapeutic option for managing symptons of multiple sclerosis (MS), a chronic…